BioCorteX is a pioneering biotech company that leverages its 'Unified Biology' approach and advanced technology platform to transform drug discovery and development. Their Carbon Mirror™ platform, a foundational biology emulator, uses a vast knowledge graph of microbiome samples and AI to conduct in-silico trials, predicting drug-bacteria interactions and optimizing treatment responses for various diseases. This aims to de-risk clinical trials, increase success rates, and deliver personalized therapies to patients worldwide.